Hospitalist · Manhasset, NY
NPI
1235556325
Since 2014
Specialty
Hospitalist
Code 208M00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
300 Community Dr
Manhasset, NY, 11030
Phone (516) 562-4764
Groups this clinician bills Medicare through
Medicare paid, 2024
$354K
4,689 services
Medicare patients, 2024
356
Average age 80
Drug cost, 2024
$589K
6,648 prescriptions
Company payments, 2025
$44.35
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dev V Shah was code 99308 (snf e&m), 3,965 times for 329 patients. In total Dev V Shah billed 4,689 services in 4 codes, and Medicare paid $354K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 3,965 | 329 | $65.90 | $261K |
| 99306 SNF E&M | Facility | 324 | 238 | $161.44 | $52K |
| 99309 SNF E&M | Facility | 270 | 148 | $95.78 | $26K |
| 99316 SNF E&M | Facility | 130 | 123 | $114.11 | $15K |
By year: 2022 $261K for 3,849 services; 2023 $267K for 3,565 services; 2024 $354K for 4,689 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dev V Shah prescribed most often to Medicare patients was Atorvastatin Calcium, with 289 prescriptions and refills. In total Dev V Shah wrote 6,648 Medicare prescriptions that cost $589K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 289 | 289 | 96 | $3,425 |
| Amlodipine Besylate Generic | 212 | 212 | 67 | $1,638 |
| Sodium Chloride 0.9 % Sodium Chloride | 189 | 189 | 59 | $9,128 |
| Eliquis Apixaban | 188 | 188 | 38 | $60K |
| Levothyroxine Sodium Generic | 181 | 181 | 50 | $2,494 |
| Metoprolol Tartrate Generic | 154 | 154 | 42 | $1,372 |
| Gabapentin Generic | 148 | 150 | 43 | $1,843 |
| Pantoprazole Sodium Generic | 133 | 133 | 56 | $8,987 |
| Furosemide Generic | 127 | 127 | 35 | $792 |
| Famotidine Generic | 125 | 125 | 38 | $1,422 |
| Sertraline Hcl Generic | 102 | 102 | 26 | $899 |
| Mirtazapine Generic | 94 | 94 | 23 | $2,146 |
| Tamsulosin Hcl Generic | 93 | 93 | 33 | $1,426 |
| Ipratropium-Albuterol Ipratropium/Albuterol Sulfate | 92 | 92 | 38 | $2,426 |
| Memantine Hcl Generic | 92 | 92 | 20 | $2,389 |
Brand drugs: 1,172 claims; generic drugs: 5,451 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dev V Shah $44.35 ($44.35 in general payments such as food, travel and fees) from 1 company. The largest payer was Teva Pharmaceuticals USA, Inc. with $44.35.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $44.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.